Expanded Clinical Study of the Tendyne Mitral Valve System

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 191 participants.

Also called NCT02321514

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 191 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02321514
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, France, Germany, Italy, Netherlands, Norway, Sweden, Switzerland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02321514. Allocation not applicable; no masking; primary purpose treatment. Start 2014-11 (actual); primary completion 2020-07 (actual). Results posted on 2021-09-02.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Expanded Clinical Study of the Tendyne Mitral Valve System
Condition
Mitral Valve Regurgitation
Intervention (Device)
Tendyne Mitral Valve System
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct02321514
Content hash
287b5105d95ed426b77e7a00d6ae394d196954505d68f8d667f17d0bde0b0c93